VolitionRX Ltd (VNRX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... [Yahoo! Finance]
VolitionRX Limited (VNRX)
NASDAQ:AMEX Investor Relations:
ir.volitionrx.com
Company Research
Source: Yahoo! Finance
Year-to-Date Revenue: Approximately $730,000 from veterinary kits and key components. Third Quarter Revenue: $475,000, a growth of 187% year-on-year. Total Revenue for Nine Months: $1 million, a growth of 96% over the same period in 2023. New Q Vet Cancer Tests Sold: Over 110,000 tests sold in the first three quarters of 2024, nearly double the total sold in 2023. Operating Expenses: Reduced by 28% compared to the same quarter last year. Cash Used in Operating Activities: $5.4 million in the third quarter, down 36% year-on-year. Cash and Cash Equivalents: Approximately $5.4 million at the end of the quarter. Non-Dilutive Funding: Commitments of over $2.2 million received from agencies within the Walloon region, Belgium. Warning! GuruFocus has detected 6 Warning Signs with VNRX. Release Date: November 15, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript VolitionRX Ltd ( VNRX ) reported significant growth in
Show less
Read more
Impact Snapshot
Event Time:
VNRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VNRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VNRX alerts
High impacting VolitionRX Limited news events
Weekly update
A roundup of the hottest topics
VNRX
News
- VolitionRx Limited (NYSE: VNRX) had its "hold" rating re-affirmed by analysts at Benchmark Co..MarketBeat
- VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- VolitionRx Limited Announces Third Quarter 2024 Financial Results and Business UpdatePR Newswire
- VolitionRX Ltd (VNRX) Q3 2024 Earnings Report Preview: What to Look For [Yahoo! Finance]Yahoo! Finance
- VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
VNRX
Earnings
- 11/14/24 - In-Line
VNRX
Sec Filings
- 11/14/24 - Form 10-Q
- 11/14/24 - Form 8-K
- 11/14/24 - Form SC
- VNRX's page on the SEC website